医疗推进剂的全球市场:类型·用途·终端用户 (医疗设备製造商·CMO·研究实验室)·不同地区的预测 (～2032年)

全球医用推进剂市场规模预计将从2023年的2.7亿美元成长到2024年的3亿美元，预测期内复合年增长率为10.16%，到2032年将达到7.2亿美元。增长至 10,000,000 美元。

医用推进剂市场可能会受到呼吸系统疾病盛行率上升的重大影响，包括慢性阻塞性肺病 (COPD) 和气喘。其影响是对使用推进剂的吸入疗法和设备的需求增加。呼吸系统疾病的流行增加了对吸入器的需求，这是我正在使用的将药物输送到肺部的重要设备。

区域展望

2023年，北美地区占据最大的市场占有率。就成长率而言，欧洲预计在预测期内也将呈现最高的复合年增长率。

在支持性的监管环境、技术进步和不断增长的医疗保健要求的推动下，北美市场的特点是强劲增长。此外，对研发和先进医疗基础设施的大量投资促进了尖端医疗推进剂的开发，并引领了该地区的市场。

欧洲医用推进剂市场的特点是推进剂配方的开发取得了进展。欧洲製药业成熟，拥有强大的分销管道、合作伙伴关係并遵守严格的欧洲法规。因此，我们的产品符合安全性和有效性的高标准，赢得了消费者的信任。人口老化导致呼吸系统疾病盛行率增加，进一步加剧了对高品质吸入器的需求。

由于各种关键因素，预计亚太地区在预测期内也将呈现强劲成长。中国、印度和日本等国家医疗保健基础设施的快速扩张和医疗保健基础设施投资的增加推动了对使用医用推进剂的高性能吸入器的需求。

本报告提供全球医疗推进剂的市场调查，彙整市场定义和概要，市场成长的各种影响因素分析，市场规模的转变·预测，各种区分·地区/各主要国家的明细，竞争环境，主要企业简介等资讯。

目录

第1章 摘要整理

第2章 市场概要

第3章 调查手法

第4章 市场动态

• 促进因素
  • 气喘和慢性阻塞性肺病等呼吸系统疾病的发生率增加
  • 吸入器的技术进步
  • 提高预防保健意识
• 阻碍因素
  • 先进推进剂成本高昂
• 机会
  • 新兴市场

第5章 市场要素分析

• 波特的五力分析
• COVID-19对全球医疗推进剂市场带来的影响

第6章 全球医疗推进剂市场:各类型

• 概要
• HFA 134A
• HFA 227EA
• HFA 152A

第7章 全球医疗推进剂市场:各用途

• 概要
• 发表会定量吸入器
• 呼吸工作式定量吸入器

第8章 全球医疗推进剂市场:各终端用户

• 概要
• 医疗设备企业
• CMO
• 研究实验室

第9章 全球医疗推进剂市场:各地区

• 概要
• 北美
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 其他
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 其他
• 其他地区
  • 中东·非洲
  • 南美

第10章 竞争情形

• 市场占有率分析
• 竞争仪表板
• 上市公司的股票概要
• 比较分析:主要企业的财务
• 主要的展开·成长策略

第11章 企业简介

• KOURA
• SRF
• DAIKIN CHEMICAL EUROPE GMBH
• LINDE PLC
• XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
• JIANGSU JULY CHEMICAL CO., LTD.
• BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
• ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
• ZHEJIANG FOTECH INTERNATIONAL CO., LTD
• CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.

第12章 资料的引用

Global Medical Propellants Market Research Report Information by Type (HFA 134A, HFA 227EA, HFA152A), By Application (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By End User (Medical Device Companies, Contract Manufacturing Organization (CMO), and Research Laboratories) And by Region (North America, Europe, Asia-Pacific, And Rest Of The World) Forecast Till 2032

Market Overview

In 2023, the Medical Propellants Market was estimated to be worth USD 0.27 billion. The industry is anticipated to experience a compound annual growth rate (CAGR) of 10.16% from USD 0.30 billion in 2024 to USD 0.72 billion by 2032 during the forecast period (2024-2032). The global metered-dose inhaler market is experiencing growth due to the increasing prevalence of respiratory conditions, including chronic obstructive pulmonary disease and asthma, as well as technological innovation in inhalation devices.

There is a significant likelihood that the medical propellants market will be significantly affected by the rising prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma. This effect is primarily the result of an increase in the demand for inhalation-based remedies and devices that utilize propellants. The demand for inhalers, which are essential devices for delivering medication to the lungs, is on the rise as respiratory maladies become more prevalent. These inhalers employ propellants to ensure that the medication is delivered effectively.

Market segment insights

The Medical Propellants Market has been segmented into HFA 134A, HFA 227EA, and HFA-152A based on type.

The Market has been segmented into manual metered dose inhalers and breath metered dose inhalers based on application.

According to the end user, the market has been divided into three categories: medical device companies, contract manufacturing organizations (CMOs), and research laboratories.

Regional Perspectives

In 2023, the market share that North America possessed was the most significant. Nevertheless, Europe is anticipated to experience the most significant compound annual growth rate (CAGR) during the 2024-2032 forecast period.

Robust growth is the hallmark of the Medical Propellants market in North America, which is driven by a supportive regulatory environment, technological advancements, and increased healthcare requirements. Additionally, the market is driven by the development of state-of-the-art Medical Propellants, which is made possible by a substantial investment in research and development and a sophisticated healthcare infrastructure.

Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe, follows the Americas region. The Medical Propellants market in Europe is characterized by the ongoing development of propellant formulations. The pharmaceutical sector in Europe is mature, which guarantees a strong distribution channel, collaborations, and adherence to stringent European regulations. This ensures that the products meet high safety and efficacy standards, which instills confidence in consumers. The demand for sophisticated, high-quality inhalers is further exacerbated by the aging population, which is driving the rise in the prevalence of respiratory diseases.

Over the forecast period, the Asia-Pacific region is anticipated to experience robust development, which is driven by a variety of key factors. It is also projected to be the fastest-growing region. The demand for sophisticated inhalers that utilize medical propellants is being driven by the rapid expansion of healthcare infrastructure and the increasing investments in healthcare infrastructure in countries such as China, India, and Japan.

Major Players

Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd. (China) are among the key companies in the Medical Propellants Market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION

A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.

• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 Data Mining Process
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 Secondary Research data flow:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 Primary Research DATA FLOW:
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 Revenue Analysis Approach
• 3.7 DATA FORECASTING
  • 3.7.1 Data forecasting Type
• 3.8 DATA MODELING
  • 3.8.1 microeconomic factor analysis:
  • 3.8.2 Data modeling:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 Rising incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
  • 4.2.2 Technological Advancements in Inhalation Devices
  • 4.2.3 Increased awareness about preventive healthcare
• 4.3 RESTRAINTS
  • 4.3.1 High costs of advanced propellants
• 4.4 OPPORTUNITY
  • 4.4.1 Emerging markets offer significant growth opportunities

5 MARKET FACTOR ANALYSIS

• 5.1 PORTER'S FIVE FORCES MODEL
  • 5.1.1 Threat of New Entrants
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 Threat of Substitutes
  • 5.1.4 Bargaining Power of Buyers
  • 5.1.5 Intensity of Rivalry
• 5.2 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL PROPELLANTS MARKET

6 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE

• 6.1 OVERVIEW
• 6.2 HFA 134A
• 6.3 HFA 227EA
• 6.4 HFA-152A

7 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 PRESS METERED DOSE INHALERS
• 7.3 BREATH ACTUATED METERED DOSE INHALERS

8 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 MEDICAL DEVICE COMPANIES
• 8.3 CONTRACT MANUFACTURING ORGANIZATION (CMO)
• 8.4 RESEARCH LABORATORIES

9 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 us
  • 9.2.2 canada
• 9.3 EUROPE
  • 9.3.1 Germany
  • 9.3.2 France
  • 9.3.3 UK
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 ASIA-PACIFIC
  • 9.4.1 China
  • 9.4.2 India
  • 9.4.3 Japan
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia-Pacific
• 9.5 REST OF THE WORLD
  • 9.5.1 middle east & africa
  • 9.5.2 south america

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 MARKET SHARE ANALYSIS,
• 10.3 COMPETITOR DASHBOARD
• 10.4 PUBLIC PLAYERS STOCK SUMMARY
• 10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
• 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.6.1 Facility expansion

11 COMPANY PROFILES

• 11.1 KOURA
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 products OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 SRF
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 Product OFFERed
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 KEY STRATEGIES
• 11.3 DAIKIN CHEMICAL EUROPE GMBH
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 productS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 LINDE PLC
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 productS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
  • 11.5.1 COMPANY OVERVIEW
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 SWOT ANALYSIS
  • 11.5.6 KEY STRATEGIES
• 11.6 JIANGSU JULY CHEMICAL CO., LTD.
  • 11.6.1 COMPANY OVERVIEw
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 Product OFFERed
  • 11.6.4 KEY DEVELOPMENTS
  • 11.6.5 KEY STRATEGIES
• 11.7 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 Product OFFERed
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 KEY STRATEGIES
• 11.9 ZHEJIANG FOTECH INTERNATIONAL CO., LTD
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 Product OFFERed
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 SWOT ANALYSIS
  • 11.9.6 KEY STRATEGIES
• 11.10 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 Product OFFERed
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 DATA CITATIONS

LIST OF TABLES

• TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
• TABLE 2 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 3 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 4 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (USD MILLION)
• TABLE 5 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 134A, BY REGION, 2019-2032 (METRIC TON)
• TABLE 6 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (USD MILLION)
• TABLE 7 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA 227EA, BY REGION, 2019-2032 (METRIC TON)
• TABLE 8 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (USD MILLION)
• TABLE 9 GLOBAL MEDICAL PROPELLANTS MARKET, FOR HFA-152A, BY REGION, 2019-2032 (METRIC TON)
• TABLE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 11 GLOBAL MEDICAL PROPELLANTS MARKET, FOR PRESS METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 12 GLOBAL MEDICAL PROPELLANTS MARKET, FOR BREATH ACTUATED METERED DOSE INHALERS, BY REGION, 2019-2032 (USD MILLION)
• TABLE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 14 GLOBAL MEDICAL PROPELLANTS MARKET, FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 15 GLOBAL MEDICAL PROPELLANTS MARKET, FOR CONTRACT MANUFACTURING ORGANIZATION (CMO), BY REGION, 2019-2032 (USD MILLION)
• TABLE 16 GLOBAL MEDICAL PROPELLANTS MARKET, FOR RESEARCH LABORATORIES, BY REGION, 2019-2032 (USD MILLION)
• TABLE 17 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2019-2032 (USD MILLION)
• TABLE 18 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 19 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 20 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 21 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 22 NORTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 23 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 24 US: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 25 US: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 26 US: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 27 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 28 CANADA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 29 CANADA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 30 CANADA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 31 EUROPE: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 32 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 33 EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 34 EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 35 EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 36 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 37 GERMANY: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 38 GERMANY: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 39 GERMANY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 40 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 41 FRANCE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 42 FRANCE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 43 FRANCE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 44 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 45 UK: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 46 UK: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 47 UK: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 48 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 49 ITALY MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 50 ITALY MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 51 ITALY: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 52 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 53 SPAIN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 54 SPAIN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 55 SPAIN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 56 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 57 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 58 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 59 REST OF EUROPE: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 60 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 61 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 62 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 63 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 64 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 65 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 66 CHINA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 67 CHINA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 68 CHINA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 69 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 70 INDIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 71 INDIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 72 INDIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 73 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 74 JAPAN: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 75 JAPAN: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 76 JAPAN: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 77 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 78 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 79 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 80 AUSTRALIA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 81 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 82 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 83 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 84 SOUTH KOREA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 85 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 86 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 87 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 88 REST OF ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 89 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
• TABLE 90 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 91 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 92 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 93 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 94 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 95 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 96 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 97 MIDDLE EAST & AFRICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 98 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (USD MILLION)
• TABLE 99 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY TYPE, 2019-2032 (METRIC TON)
• TABLE 100 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2019-2032 (USD MILLION)
• TABLE 101 SOUTH AMERICA: MEDICAL PROPELLANTS MARKET, BY END USER, 2019-2032 (USD MILLION)
• TABLE 102 FACILITY EXPANSION
• TABLE 103 KOURA: PRODUCT OFFERED
• TABLE 104 KOURA: KEY DEVELOPMENT
• TABLE 105 SRF: PRODUCTS OFFERED
• TABLE 106 DAIKIN CHEMICAL EUROPE GMBH: PRODUCT OFFERED
• TABLE 107 LINDE PLC: PRODUCT OFFERED
• TABLE 108 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: PRODUCTS OFFERED
• TABLE 109 JIANGSU JULY CHEMICAL CO., LTD.: PRODUCTS OFFERED
• TABLE 110 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: PRODUCTS OFFERED
• TABLE 111 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
• TABLE 112 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: PRODUCTS OFFERED
• TABLE 113 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.: PRODUCTS OFFERED

LIST OF FIGURES

• FIGURE 1 GLOBAL MEDICAL PROPELLANTS MARKET: STRUCTURE
• FIGURE 2 GLOBAL MEDICAL PROPELLANTS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
• FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
• FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
• FIGURE 5 PORTER'S FIVE FORCES ANALYSIS: GLOBAL MEDICAL PROPELLANTS MARKET
• FIGURE 6 GLOBAL MEDICAL PROPELLANTS MARKET, TYPE, 2023 & 2032 (USD MILLION)
• FIGURE 7 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE, 2023 & 2032 (USD MILLION)
• FIGURE 8 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY TYPE,
• FIGURE 9 GLOBAL MEDICAL PROPELLANTS MARKET, APPLICATION, 2023 & 2032 (USD MILLION)
• FIGURE 10 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
• FIGURE 11 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY APPLICATION,
• FIGURE 12 GLOBAL MEDICAL PROPELLANTS MARKET, END USER, 2023 & 2032 (USD MILLION)
• FIGURE 13 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
• FIGURE 14 GLOBAL MEDICAL PROPELLANTS MARKET SHARE (%), BY END USER,
• FIGURE 15 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
• FIGURE 16 GLOBAL MEDICAL PROPELLANTS MARKET SHARE, BY REGION, 2023 (% SHARE)
• FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 18 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 19 NORTH AMERICA MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 20 EUROPE MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 21 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 22 EUROPE MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 23 ASIA-PACIFIC MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 24 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 25 ASIA-PACIFIC: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 26 REST OF THE WORLD: MARKET ANALYSIS: MEDICAL PROPELLANTS MARKET, 2019-2032 (USD MILLION)
• FIGURE 27 REST OF THE WORLD: MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)
• FIGURE 28 REST OF THE WORLD MEDICAL PROPELLANTS MARKET SHARE, BY COUNTRY, 2023 (%)
• FIGURE 29 GLOBAL MEDICAL PROPELLANTS MARKET PLAYERS: COMPETITIVE ANALYSIS,
• FIGURE 30 COMPETITOR DASHBOARD: GLOBAL MEDICAL PROPELLANTS MARKET
• FIGURE 31 KOURA: SWOT ANALYSIS
• FIGURE 32 SRF: FINANCIAL OVERVIEW SNAPSHOT
• FIGURE 33 LINDE PLC SWOT ANALYSIS
• FIGURE 34 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD: SWOT ANALYSIS
• FIGURE 35 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.: SWOT ANALYSIS
• FIGURE 36 ZHEJIANG FOTECH INTERNATIONAL CO., LTD.: SWOT ANALYSIS